Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Immunotec Inc Announces Management Change

Friday, 14 Jun 2013 04:16pm EDT 

Immunotec Inc announced that appointment of Mr. Rod Budd, who has been a director since 2011, as Chairman of the Board, and of Mr. Charles Roberts, one of the founders of the Corporation, as Chairman Emeritus of the Corporation, the ratification of the appointment of Mr. Charles Orr as Chief Executive Officer (CEO) of the Corporation as of June 1, 2013. 

Company Quote

0.01 +3.33%
17 Apr 2015